Maxims of Tech: Rules of Engagement for a Fast Changing Environment

3 Things In Biotech You Should Learn Today: February 12, 2018 - Seeking Alpha

 
 
Seeking Alpha3 Things In Biotech You Should Learn Today: February 12, 2018Seeking AlphaSummary. Another blood vessel blocker/immunotherapy combo steps up, now for Merck. And speaking of Pfizer.(now in lung cancer). Aveo shows more signs of benefit in kidney cancer. Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an ...
 
Related NewsFeeds

Rotating Night Shifts a Path to DiabetesWebMDTUESDAY, Feb. 20, 2018 (HealthDay News) -- Working the night shift may play havoc with your blood sugar levels, a new study contends. For the study, resear

11 visits

Invenshure portfolio company, OneOme, named #2 of 2018 World's Most Innovative Biotech Companies by Fast ...PR Newswire (press release)The OneOme platform was co-developed and exclusively licensed

0 visits

News-Medical.netWomen with Type 1 diabetes come across unique challengesNews-Medical.netWhen diagnosed at a young age with Type 1 diabetes, the disease affects girls and boys equally. However, that ch

0 visits

Factors to Consider for Left-Sided Metastatic CRCTargeted OncologyWe have data from prior phase III CALGB 804045 and data from various studies that suggest that perhaps in this group of patients, EGFR

0 visits

Endpoints NewsSenior R&D exec Sue Dillon jumps ship at J&J, launches mystery biotech startup Aro with Centyrins techEndpoints NewsTwo former executive heavyweights at Johnson & Johnson have left the p

0 visits

Endpoints NewsTop Pfizer research exec John Davis joins migration to biotech, lands at Magenta as CMOEndpoints NewsSue Dillon isn't the only Big Pharma R&D exec to make news this week after making

0 visits

Endpoints NewsEx-HHS Secretary Tommy Thompson adds another biotech to his resume; Medigene OK'd for first TCR clinical trialEndpoints NewsFormer HHS Secretary Tommy Thompson is expanding his biote

0 visits

Laddered treatment for pityriasis rubra pilarisModernMedicineFor some patients with pityriasis rubra pilaris (PRP) who do not respond to standard systemic treatments, biologic therapy may result in ma

0 visits

The OutlineIf your Apple Watch knows you'll get diabetes, who can it tell?The OutlineCardiogram's machine learning algorithm, called "DeepHeart,? ingested large amounts of health data, like he

0 visits

Mainline TodayRegenerative Medicine is the Pain Management Alternative You've Been Looking ForMainline TodayInjuries happen to almost everyone, but for some they can be far worse. For those with c

0 visits

Ustekinumab shows promise for reducing psoriasis-associated cardiovascular comorbidityModernMedicine"What's surprising is that we all believed that TNF inhibitors would lower aortic vascular infla

0 visits

MobiHealthNewsRoche's Accu-Chek diabetes management app receives its fifth FDA recallMobiHealthNewsRoche's Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On F

0 visits

Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with DiabetesGlobeNewswire (press release)"Early feedback on the Mio Advance infusion set has been fantastic," said Annette Brü

0 visits

GlobeNewswire (press release)CBS News Covers AXIM Biotech's Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid ...GlobeNewswire (press release)AXIM Biotechnologies, I

0 visits

Endpoints NewsOn a journey to find and fuel new biotech ventures, Arix adds France's Ipsen to its network of partnersEndpoints NewsArix Bioscience is clearly in a deal-making mood, striking a new

0 visits

Meat & PoultrySmithfield and the Univ. of Virginia partner on researchMeat & PoultryGeorge Christ, a UVA professor of biomedical engineering and orthopedic surgery, Mary Muilenburg Stamp professor of

0 visits

Seeking AlphaBioTime May Very Well Be The Wayne Gretzky Of Clinical Stage Biotech CompaniesSeeking AlphaBioTime (BTX) may very well be the Wayne Gretzky of clinical stage biotech companies with countl

20 visits

Pharmaceutical ProcessingMerck takes out Aussie biotech Viralytics for $394MSeeking AlphaMerck (NYSE:MRK) has agreed to acquire Sydney, Australia-based Viralytics for AUD 1.75 per share in cash, repre

0 visits

Press TelegraphBellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of DirectorsGlobeNewswire (press release)HOUSTON, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc.

0 visits

CNNCan you vaccinate yourself against cancer? - CNN - CNN.comCNNStudies touting the benefits of cancer vaccines are emerging, but do those studies really show hope or just hype?Cancer Vaccines May Ove

0 visits

 
LithoVision 2018